SAN DIEGO, July 6, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, will present a corporate update at the Cantor Fitzgerald Healthcare Conference in New York, NY, on July 8, 2015.
Cantor Fitzgerald Healthcare Conference
| Date: | Wednesday, July 8, 2015 |
| Time: | 1:00 pm Eastern Time / 10:00 am Pacific Time |
| Location: | New York City |
The presentation will be webcast live and archived for 30 days on Zogenix’s Investor Relations website at ir.zogenix.com.
About Zogenix
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.
For more information, visit www.zogenix.com.
CONTACT: Investors: Andrew McDonald Founding Partner, LifeSci Advisors LLC 646-597-6987 | Andrew@lifesciadvisors.com Media: Catherine O’Connor Sr. Director, Corporate Communications, Zogenix 858.436.3374 | coconnor@zogenix.com
Help employers find you! Check out all the jobs and post your resume.
